Trial Profile
DS-7113b phase II study -A DS-7113b potency ratio assessment study in patients with cancer pain.-
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Feb 2022
Price :
$35
*
At a glance
- Drugs Hydromorphone (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Company
- 26 May 2016 New trial record